JANX - Janux Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

JANX is currently covered by 7 analysts with an average price target of $64.24. This is a potential upside of $40.19 (167.11%) from yesterday's end of day stock price of $24.05.

Janux Therapeutics's activity chart (see below) currently has 11 price targets and 37 ratings on display. The stock rating distribution of JANX is 88.89% BUY and 11.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.23% with an average time for these price targets to be met of 270.71 days.

Highest price target for JANX is $200, Lowest price target is $45, average price target is $86.29.

Most recent stock forecast was given by BRADLEY CANINO from STIFEL on 10-Sep-2025. First documented stock forecast 06-Jul-2021.

Currently out of the existing stock ratings of JANX, 24 are a BUY (88.89%), 3 are a HOLD (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$45

$20.95 (87.11%)

$115

3 days ago
(10-Sep-2025)

0/3 (0%)

$20.69 (85.11%)

Buy

$70

$45.95 (191.06%)

$70

6 months 10 days ago
(03-Mar-2025)

10/12 (83.33%)

$38.17 (119.92%)

252

Buy

$200

$175.95 (731.60%)

$200

9 months 2 days ago
(11-Dec-2024)

1/7 (14.29%)

$136.55 (215.21%)

966

Hold

$62

$37.95 (157.80%)

$42

9 months 9 days ago
(04-Dec-2024)

3/3 (100%)

$-4.84 (-7.24%)

7

Buy

$105

$80.95 (336.59%)

$70

9 months 10 days ago
(03-Dec-2024)

0/2 (0%)

$45.14 (75.41%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is JANX (Janux Therapeutics) average time for price targets to be met?

On average it took 270.71 days on average for the stock forecasts to be realized with a an average price target met ratio 53.23

Which analyst has the current highest performing score on JANX (Janux Therapeutics) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the current lower performing score on JANX (Janux Therapeutics) with a proven track record?

SOUMIT ROY

Which analyst has the most public recommendations on JANX (Janux Therapeutics)?

Swayampakula Ramakanth works at HC WAINWRIGHT and has 5 price targets and 6 ratings on JANX

Which analyst is the currently most bullish on JANX (Janux Therapeutics)?

Josh Schimmer with highest potential upside - $175.95

Which analyst is the currently most reserved on JANX (Janux Therapeutics)?

Bradley Canino with lowest potential downside - $20.95

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?